Form 4: Cassava Sciences CEO Buys Shares
Insider Transaction (Form 4)
Richard Barry, President & CEO and a Director of Cassava Sciences Inc, purchased 132,926 shares of common stock on November 17, 2026 for $0.48 per share.
Summary
- Open-market purchase: acquired 132,926 Common Stock at $0.48 ($63,804) on November 17, 2026; holds 1,911,096 after (Indirect).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $63,804, committing personal capital to the stock.
Insider Transactions
Richard Barry — Director, Officer (President & CEO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-11-17 | Open-market purchase | Common Stock | 132,926 | $0 | $63.8K | 1,911,096 |
Key Dates
| Date | Description |
|---|---|
| 2026-11-17 | Open-market purchase (132,926 shares) |
Keywords
insider transaction, Form 4, FLNA, FILANA THERAPEUTICS, INC., bullish, Richard Barry
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.